In Vivo Study Paths Explained: Pros and Cons from CROs to Private Labs

Choosing the right in vivo study lab can be challenging. Whether it’s an academic facility, outsourced provider, or contract vivaria, they all offer unique benefits that can complicate your decision.

This webinar is designed to help you confidently navigate those choices and align your study path with your project goals. If you’re part of a research team, biotech startup, or pharma organization, you’ll gain practical insights to sharpen your preclinical strategy and better use your in vivo resources.

Join us and you’ll learn:

• The four primary options for executing in vivo studies
• Pros, cons, and key decision factors for each approach
• How to assess internal versus external execution capabilities
• Common mistakes teams make, and how to avoid them
• Real-world examples of hybrid strategies used by startups to pharma leaders

If you’re planning early pharmacology studies or preparing for regulatory-aligned efficacy programs, this webinar will give you a clear framework to choose the best execution path for your needs.